0

523144

MEDICAPQ

img img img img
No Data Available

MEDI-CAPS LTD. Share Price Update

As of the latest trading session, MEDI-CAPS LTD. is trading at ₹31.35, up by ₹0.35 or 1.12% from its previous close. The stock has moved between ₹30.86 and ₹32.62 today. Over the past year, the stock has delivered a return of -25.69%. In the last month, it has returned 14.16%.

Investment Returns

Over 1 Month 14.16% Over 3 Months 27.95% Over 6 Months -15.86% Over 1 Year -25.69%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDI-CAPS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 39.10
  • P/E Ratio (TTM) 44.15
  • Beta 0.90
  • Book Value / share 54.25
  • Return on equity 0.27%
  • EPS (TTM) 0.71
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.29
info icon alternate text

MEDI-CAPS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 0.77
Operating Expense 0.63
Net Profit 0.29
Net Profit Margin (%) 37.66
Earnings Per Share (EPS) 0.23
EBITDA 0.35
Effective Tax Rate (%) 9.67
Particulars SEP 2025 (Values in Cr)
Revenue 1.00
Operating Expense 0.72
Net Profit 0.29
Net Profit Margin (%) 28.99
Earnings Per Share (EPS) 0.23
EBITDA 0.32
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.71
Net Profit -0.40
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.32
EBITDA -0.36
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.88
Operating Expense 0.72
Net Profit 0.71
Net Profit Margin (%) 80.68
Earnings Per Share (EPS) 0.57
EBITDA 0.48
Effective Tax Rate (%) -61.36
Particulars DEC 2024 (Values in Cr)
Revenue 0.25
Operating Expense 0.61
Net Profit -0.26
Net Profit Margin (%) -104.00
Earnings Per Share (EPS) -0.21
EBITDA -0.22
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.37
Operating Expense 2.69
Net Profit 0.56
Net Profit Margin (%) 23.62
Earnings Per Share (EPS) 0.45
EBITDA 0.44
Effective Tax Rate (%) -93.10
Particulars MAR 2024 (Values in Cr)
Revenue 6.93
Operating Expense 2.49
Net Profit 3.89
Net Profit Margin (%) 56.13
Earnings Per Share (EPS) 3.12
EBITDA 4.99
Effective Tax Rate (%) 19.46
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.49
Net Profit 0.15
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.35
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.67
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA 0.03
Effective Tax Rate (%) -16.66
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit -0.11
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.90
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 97.25
ROE % -1.94
ROCE % -2.11
Total Debt to Total Equity 0.00
EBITDA Margin -3.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 97.02
ROE % -2.03
ROCE % -1.16
Total Debt to Total Equity 0.00
EBITDA Margin 1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.09
ROE % 1.05
ROCE % 3.68
Total Debt to Total Equity 0.00
EBITDA Margin 12.31
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.23
ROE % 9.12
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 17.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.97
ROE % 11.38
ROCE % 11.42
Total Debt to Total Equity 0.00
EBITDA Margin 21.70
Particulars MAR 2025 (Values in Cr)
Book Value / Share 54.00
ROE % 0.27
ROCE % -0.13
Total Debt to Total Equity 0.00
EBITDA Margin 2.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.32
ROE % 6.10
ROCE % 7.57
Total Debt to Total Equity 0.00
EBITDA Margin 69.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 49.00
ROE % -0.80
ROCE % -0.62
Total Debt to Total Equity 0.00
EBITDA Margin -290.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 49.15
ROE % -0.82
ROCE % -0.87
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.89
ROE % 0.02
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 125.42
Total Liabilities 125.42
Total Equity 121.27
Share Outstanding 1
Price to Book Ratio 0.77
Return on Assets (%) -0.45
Return on Capital (%) -0.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.32
Total Assets 127.28
Total Liabilities 127.28
Total Equity 120.98
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) -1.76
Return on Capital (%) -1.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.11
Total Assets 125.98
Total Liabilities 125.98
Total Equity 118.57
Share Outstanding 1
Price to Book Ratio 0.71
Return on Assets (%) 1.39
Return on Capital (%) 1.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 9.75
Total Assets 130.35
Total Liabilities 130.35
Total Equity 116.25
Share Outstanding 1
Price to Book Ratio 1.01
Return on Assets (%) 7.73
Return on Capital (%) 8.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.80
Total Assets 114.81
Total Liabilities 114.81
Total Equity 104.71
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) 9.69
Return on Capital (%) 10.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 68.02
Total Liabilities 68.02
Total Equity 67.34
Share Outstanding 1
Price to Book Ratio 0.77
Return on Assets (%) 0.81
Return on Capital (%) 0.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 68.09
Total Liabilities 68.09
Total Equity 66.48
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) 5.71
Return on Capital (%) 5.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 61.62
Total Liabilities 61.62
Total Equity 61.10
Share Outstanding 1
Price to Book Ratio 0.71
Return on Assets (%) 0.23
Return on Capital (%) 0.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 61.80
Total Liabilities 61.80
Total Equity 61.28
Share Outstanding 1
Price to Book Ratio 1.01
Return on Assets (%) -0.06
Return on Capital (%) -0.06
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.72
Total Assets 62.63
Total Liabilities 62.63
Total Equity 60.96
Share Outstanding 1
Price to Book Ratio 0.83
Return on Assets (%) -0.17
Return on Capital (%) -0.18
Particulars MAR 2025 (Values in Cr)
Net Income -0.84
Cash from Operations 4.81
Cash from Investing -4.97
Cash from Financing 0.00
Net change in Cash 0.09
Free Cash Flow 5.13
Particulars MAR 2024 (Values in Cr)
Net Income -1.24
Cash from Operations 7.94
Cash from Investing -7.73
Cash from Financing 0.00
Net change in Cash -0.79
Free Cash Flow 8.29
Particulars MAR 2023 (Values in Cr)
Net Income 4.92
Cash from Operations -3.02
Cash from Investing -2.56
Cash from Financing 0.00
Net change in Cash -8.64
Free Cash Flow -1.86
Particulars MAR 2022 (Values in Cr)
Net Income 10.05
Cash from Operations 7.02
Cash from Investing -4.07
Cash from Financing 0.00
Net change in Cash 2.94
Free Cash Flow 9.81
Particulars MAR 2021 (Values in Cr)
Net Income 11.23
Cash from Operations 15.31
Cash from Investing -9.69
Cash from Financing -0.06
Net change in Cash 5.55
Free Cash Flow 17.57
Particulars MAR 2025 (Values in Cr)
Net Income 0.28
Cash from Operations 1.59
Cash from Investing -1.84
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 1.67
Particulars MAR 2024 (Values in Cr)
Net Income 4.82
Cash from Operations 4.04
Cash from Investing -3.08
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 4.04
Particulars MAR 2023 (Values in Cr)
Net Income 0.25
Cash from Operations -2.59
Cash from Investing 1.85
Cash from Financing 0.00
Net change in Cash -0.74
Free Cash Flow -2.59
Particulars MAR 2022 (Values in Cr)
Net Income -0.06
Cash from Operations -0.95
Cash from Investing 1.00
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow -0.95
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 2.23
Cash from Investing -2.18
Cash from Financing -0.06
Net change in Cash -0.01
Free Cash Flow 2.23
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
ADITYA BIRLA REAL ESTATE LIMIT 1489.70 0.00 4.49 16639.31 1080.10 2535.00
ELPRO INTERNATIONAL LTD 144.35 27.97 1.20 2446.43 71.20 149.70
FORBES & COMPANY LTD. 349.15 19.57 1.95 450.40 301.90 477.00
GOLDEN TOBACCO LIMITED 40.25 13.37 -0.33 70.88 36.00 60.90
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
SANATHNAGAR ENTERPRISES LIMITE 38.15 119.22 -0.97 12.02 29.01 54.33
BARODA RAYON CORPORATION LTD. 129.45 9.49 0.76 296.59 100.10 175.80
ADITYA BIRLA REAL ESTATE LIMIT 1489.70 108.82 3.54 16639.31 1080.10 2535.00
ELPRO INTERNATIONAL LTD 144.35 73.65 1.16 2446.43 71.20 149.70

MEDI-CAPS LTD. shareholding pattern

Holding
48.61%
51.36%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDI-CAPS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
31.35 1.12 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 31.30
  • 26 Days 28.90
  • 10 Days 30.60
  • 50 Days 28.00
  • 12 Days 30.40
  • 100 Days 28.90
  • 20 Days 29.50
  • 200 Days 32.40
31.44 PIVOT
First Support 29.88 First Resistance 32.56 Second Support 28.76 Second Resistance 34.12 Third Support 27.20 Third Resistance 35.24
RSI 58.79 ADX 36.48 MACD 1.45 Williams % R -46.55 Commodity Channel Index (CCI) 85.51
Date 2026-05-08 Week 6851.00 Same Day 399.00 Month 3367.00
1 Year 0.90 3 Year 0.68
Over 1 Month
14.16% down
Over 1 Year
-25.69% down
Over 3 Months
27.95% down
Over 3 Years
-6.83% down
Over 6 Months
-15.86% down
Over 5 Years
-6.31% down

MEDI-CAPS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2012 1.5 Final 24 Sep 2012 Equity shares
22 Sep 2011 1.5 Final 24 Sep 2011 Equity shares
22 Sep 2010 1.5 Final 24 Sep 2010 Equity shares
24 Sep 2009 1.5 Final 28 Sep 2009 Equity shares
24 Sep 2008 1.5 Final 26 Sep 2008 Equity shares
20 Sep 2007 1.5 Final 24 Sep 2007 Equity shares
21 Sep 2006 0.0 Final 25 Sep 2006 Equity shares
22 Sep 2005 0.0 Final 26 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
20 Mar 2013 19 Mar 2013 3:1

Top Gainers

Top Losers

MEDI-CAPS LTD. Share Price

Medi Caps Limited was incorporated by S L Mittal in August, 1983 as a Private Limited Company and was converted into a Public Limited Company in Mar.'86. Pharmaceutical companies procure empty hard gelatine capsules from Medi Caps for dosaged medicines meant for oral administration. The company is the second-largest manufacturer of empty hard gelatine capsules in India.

It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations. Medi-caps can claim to have achieved this. In Apr.'95, the company offered 6.11 lac rights shares to part-finance the Rs 9.20 crore expansion of its manufacturing facilities by installing four high-speed automatic capsule-making machines.

The company's manufacturing unit is located in Pithampur, Madhya Pradesh. The company's clientele include US Vitamins, SOL Pharmaceuticals, Dr Reddy's Laboratories, Lupin Laboratories, Aristo Pharmaceuticals, etc. The other group company of Medi-caps is Medi-caps Finance which is engaged in finance related activities.

In 1995-96, the company enhanced the capacity of empty hard gelatine capsules by 2500 lac. The company received ISO 9002 Certification during 1998-99. It developed six sizes of the Hard Gelatin Capsules in 2002-03. The company is closely working on commissioning of 13th Machine with 100% automisation. During 2002-03 the company established the export market in countries like China, Thailand, Dubai, Malaysia, South Africa and Philippines.

The Company permanently discontinued its manufacturing activities on 21.11.2019 at the plant in Pithampur, Dhar Dist. and ventured into Real Estate Business and in continuation of this, it executed an agreement with the Tirupati Reality & Developers on 12 October, 2020 for Project named Medi Caps Business Park.

Parent organization Indian Private
NSE symbol MEDICAPS
Founded 1983
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medi Caps Ltd?

Answer Field

Medi Caps Ltd share price is for NSE ₹ 11.00 & for BSE ₹ 31.35 as on May 08 2026 03:30 PM.

What is the Market Cap of Medi Caps Ltd Share?

Answer Field

The market cap of Medi Caps Ltd for NSE ₹ 0.00 & for BSE ₹ 39.10 as on May 08 2026 03:30 PM.

What is the 52 Week High and Low of Medi Caps Ltd?

Answer Field

The 52 Week High and Low of Medi Caps Ltd for NSE is ₹ 11.00 and ₹ 0.00 and for BSE is ₹ 46.99 and ₹ 21.00.

What is 1 year return for Medi Caps Ltd?

Answer Field

The 1 year returns on the stock has been -25.69%.

What is the P/E Ratio of Medi Caps Ltd Share?

Answer Field

As on May 08 2026 03:30 PM the price-to-earnings (PE) ratio for Medi Caps Ltd share is 44.15.

What is the PB ratio of Medi Caps Ltd Share?

Answer Field

As on May 08 2026 03:30 PM, the price-to-book (PB) ratio for Medi Caps Ltd share is 54.25.

How to Buy Medi Caps Ltd Share?

Answer Field

You can trade in Medi Caps Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medi Caps Ltd Share on Bajaj Broking App?

Answer Field

To buy Medi Caps Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medi Caps Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|